🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Incredibly proud to launch this years #OvariesTalkAboutThem campaign with CAMILLA AND MARC Please join us in raising awareness & funding for our research on #OvarianCancer

Visit the #NSWRCRN website nswregionalcrn.com.au/what-we-do #CancerResearch #CapacityBuilding

The #NSWRCRN brings together health & medical professionals, researchers, cancer services & people affected by cancer from the geographical area covered by our partner LHDs: Central Coast, Hunter New England, Mid-North Coast, Northern NSW lnkd.in/gB5vqigS #CancerResearch

An update on what we have been building across regional NSW - come and join us!

Thanks for the opportunity! #NSWCancerConf23

This year's Austin Doyle Lecture will be presented by awarding-winning molecular biologist A/Prof Prof Nikola Bowden and we are delighted she will be joining us from University of Newcastle. Register now (early bird closes 1st Oct): bit.ly/30xUzyC @latrobe_cvr MonashHeart Cardiovascular Initiative, University of Sydney

That's a wrap #PoCoG2023! Thank you to all our speakers, chairs and attendees for making it an insightful, captivating and thought-provoking event👏 🔍View some of the research presented here: linkedin.com/feed/update/ur…

When your team just gets you. Thankyou Michelle Wong-Brown for the best Xmas gift ever!!

📢New preprint from my team!📢 biorxiv.org/cgi/content/sh… We use #singlecell multi-omics and parallel colony assays to characterise the heterogeneous responses of acute myeloid leukaemia (#AML) cells to #epigenetic therapies. A few highlights...

Exciting update! NSW Cancer Research Education Seminars are back Feb 20th! 📅 Heather Lee talks hypomethylating agents for AML & myelodysplasia treatment. Register at bit.ly/3SMUkeg #CancerResearch #SeminarSeries Sydney Cancer Partners SPHERE Cancer Clinical Academic Group Cancer Institute NSW #NSWRCRN

REMINDER! Join us tomorrow for the 1st NSW Cancer Research Edu Seminar! 📅Tuesday 20th Feb, 12:30- 1:30pm Heather Lee talks hypomethylating agents for AML & myelodysplasia treatment. Register at bit.ly/3SMUkeg #CancerResearch Sydney Cancer Partners SPHERE Cancer Clinical Academic Group Cancer Institute NSW

Was fabulous to have Prof Nikola Bowden presenting the Wunderly Oration for TSANZ society’s conference #TSANZ2024. Such an inspiring story of drug repurposing for ovarian cancer Hunter Medical Research Institute (HMRI)

CONGRATULATIONS to our #NSWRCRN #PhD scholar Sara who passed her PhD confirmation with flying colours! Sara is researching DNA methylation with the aim of discovering biomarkers for the development of an early detection test for ovarian cancer. What a⭐️! We're very proud

Don’t forget to register for the NSW Cancer Research Symposium on Data Linkage. REGISTRATIONS CLOSING MONDAY 10 JUNE. Program and Rego details available nswregionalcrn.com.au/our-network/20…. #CancerResearch #DataLinkage #Symposium

A reminder to link-in online tomorrow for the NSW Cancer Research Education Seminar - Tuesday 18th of June 12:30 - 1:30pm. Register here ➡ bit.ly/4aI5iYc #NSWCancerResearch #NSWRCRN

⏰If you're considering registering for the NSW Cancer Research Symposium on Data Linkage, July 4 - now's the time!🔗A few last-minute spots available! REGISTER HERE ➡ bit.ly/3VIk9hN Use the link to download the full Digital Symposium Program!

Happy to see our work on ERCC2 published today in Cell Genomics. We discovered that cancers with somatic ERCC2 mutations have a highly altered genomic distribution of somatic mutation. HKU SBMS 🧵1/n

Today is #WorldCancerResearchDay. We honour the incredible researchers improving cancer outcomes for those disproportionately impacted, including regional, rural & remote communities. Thanks to Cancer Institute NSW for the leadership & funding that make this vital work possible.

🏆Check out the Editor's Choice #Article "Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies—Therapeutic Vulnerabilities in Treatment-Resistant Subtypes" ✍by Yue Ma et al. UTS 📌Link: mdpi.com/2072-6694/16/1…

🔬 Turning old drugs into new hope for ovarian cancer. Prof Prof Nikola Bowden from University of Newcastle is leading groundbreaking research to repurpose existing medicines for treatment-resistant ovarian cancer (1/3)